ACRV1
Acrosomal protein SP-10
Also known as: ASPX_HUMAN, D11S4365, SP-10, SPACA2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P26436
- Gene
- ACRV1
- Ensembl
- ENSG00000134940
- Chromosome
- 11
- Canonical length
- 265 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Acrosome
- Secretome location
- Secreted in male reproductive system
OverviewNCBI Gene
This gene encodes a testis-specific, differentiation antigen, acrosomal vesicle protein 1, that arises within the acrosomal vesicle during spermatogenesis, and is associated with the acrosomal membranes and matrix of mature sperm. The acrosomal vesicle protein 1 may be involved in sperm-zona binding or penetration. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
265 residues, UniProt reviewed canonical sequence.
>P26436|ACRV1
1 MNRFLLLMSL YLLGSARGTS SQPNELSGSI DHQTSVQQLP GEFFSLENPS DAEALYETSS
61 GLNTLSEHGS SEHGSSKHTV AEHTSGEHAE SEHASGEPAA TEHAEGEHTV GEQPSGEQPS
121 GEHLSGEQPL SELESGEQPS DEQPSGEHGS GEQPSGEQAS GEQPSGEHAS GEQASGAPIS
181 STSTGTILNC YTCAYMNDQG KCLRGEGTCI TQNSQQCMLK KIFEGGKLQF MVQGCENMCP
241 SMNLFSHGTR MQIICCRNQS FCNKILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACRV1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 111 nTPM
Expression across tissuesHPA
Tissue
- testis: 111 nTPM
- epididymis: 3.3 nTPM
- basal ganglia: 2.3 nTPM
- cerebral cortex: 1.6 nTPM
- amygdala: 1.3 nTPM
- hippocampal formation: 1.2 nTPM
Single-cell type
- early spermatids: 1,056 nCPM
- late primary spermatocytes: 446 nCPM
- late spermatids: 332 nCPM
- sertoli cells: 9.1 nCPM
- pdcs: 4.6 nCPM
- early primary spermatocytes: 4 nCPM
Immune cell
- T-reg: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 2.2 nTPM
- basal ganglia: 2 nTPM
- hypothalamus: 1.8 nTPM
- white matter: 1.5 nTPM
- amygdala: 1.3 nTPM
- pons: 1.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.89
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ly-6 antigen/uPA receptor-like
- u-PAR/Ly-6 domain
- Acrosomal SP-10-like
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACRV1 as an antibody target. Whether an autoantibody or antibody against ACRV1 could matter depends on whether native ACRV1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACRV1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACRV1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...